Bromocriptine Mesylate
11 NDCs across 6 manufacturers|10 Generic,1 Brand
Bromocriptine Mesylate is used to treat acromegaly, adenoma, amenorrhea, galactorrhea, hyperprolactinemia and hypogonadism, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 13, 1998. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $9 million on Bromocriptine Mesylate across 38,000 claims for 7,221 beneficiaries.
Bromocriptine Mesylate is available as 11 NDCs from 6 manufacturers (10 generic, 1 brand), with NADAC prices from $1.57 to $5.45 per EA — the most expensive product costs about 3.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
10G / 1B
Manufacturers
6
competing in market
Price Spread
$1.57 – $5.45
per EA
7d Activity
avg -2.6% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
6 manufacturers producing BROMOCRIPTINE MESYLATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BROMOCRIPTINE 5 MG CAPSULE | $5.4547 per EA | — |
CYCLOSET 0.8 MG TABLET | $5.2531 per EA | -0.04% |
BROMOCRIPTINE 5 MG CAPSULE | $4.1167 per EA | — |
BROMOCRIPTINE 5 MG CAPSULE | $4.1167 per EA | — |
BROMOCRIPTINE 5 MG CAPSULE | $4.1167 per EA | — |
BROMOCRIPTINE 2.5 MG TABLET | $1.6800 per EA | — |
BROMOCRIPTINE 2.5 MG TABLET | $1.6058 per EA | -3.27% |
BROMOCRIPTINE 2.5 MG TABLET | $1.6058 per EA | -3.27% |
BROMOCRIPTINE 2.5 MG TABLET | $1.6058 per EA | -3.27% |
BROMOCRIPTINE 2.5 MG TABLET | $1.6058 per EA | -3.27% |
BROMOCRIPTINE 2.5 MG TABLET | $1.5691 per EA | — |
Frequently Asked Questions
What is Bromocriptine Mesylate used to treat?
Bromocriptine Mesylate is used to treat acromegaly, adenoma, amenorrhea, galactorrhea, hyperprolactinemia and hypogonadism, per the National Library of Medicine's MED-RT classification.
When did Bromocriptine Mesylate become available as a generic?
FDA approved the first generic Bromocriptine Mesylate (ANDA) on Jan 13, 1998. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Bromocriptine Mesylate?
In 2024, Medicare Part D spent $9 million on Bromocriptine Mesylate across 38,000 claims for 7,221 beneficiaries.
How many Bromocriptine Mesylate products are on the market?
The Bromocriptine Mesylate drug market contains 11 NDCs from 6 manufacturers — 10 generic and 1 brand product.
What is the price range for Bromocriptine Mesylate?
NADAC reference prices for Bromocriptine Mesylate range from $1.5691 to $5.4547 per EA — the most expensive product costs about 3.5× the cheapest.
Is generic Bromocriptine Mesylate cheaper than brand?
The average generic NADAC for Bromocriptine Mesylate is $2.7477 per EA, versus $5.2531 for brand-labeled products — generic is about 48% cheaper on average.
Which manufacturers make Bromocriptine Mesylate?
6 manufacturers list Bromocriptine Mesylate in NADAC. Ranked by number of NDCs, the largest are Zydus Pharmaceuticals (USA) Inc. (2), Mylan Pharmaceuticals Inc. (2), Sandoz Inc. (2), Padagis US LLC (2), ANI Pharmaceuticals, Inc. (2).
How has the price of Bromocriptine Mesylate changed recently?
Over the past 7 days, 0 Bromocriptine Mesylate NDCs rose and 5 fell, with a market-wide average change of -2.6%.